Phil Johnson started about four months ago as chief commercial officer at Evidation. He sat down on the sidelines of JP ...

The report suggests that USAID could have seen its 10,000-strong workforce reduced to just 300, with the new figure emerging ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), ...

The downsizing of health federal agencies comes after Trump threatened to pull the US out of the World Health Organisation ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

The integration of AI in healthcare as a means by which to enhance diagnostic accuracy and treatment planning also appeared ...